ASN Kidney Week Genetics in Clinical Nephrology 2025

Precision Nephrology, Genetic Kidney Disease & Clinical Genomics in Modern Renal Medicine

The ASN Kidney Week Genetics in Clinical Nephrology 2025 program provides an advanced and highly practical exploration of how genetic testing is transforming modern nephrology. Presented as a dedicated Early Program during ASN Kidney Week 2025, this intensive full-day course focuses on the real-world integration of genomic medicine into kidney disease diagnosis, transplant evaluation, hereditary nephropathies, and precision therapeutics.

As nephrology rapidly evolves beyond traditional phenotype-based diagnosis, clinicians increasingly encounter patients whose kidney disease cannot be fully explained through conventional clinical frameworks alone. In many of these cases, underlying genetic disorders are now being identified as major contributors to:

• Chronic kidney disease of unknown etiology
• Inherited nephropathies
• Glomerular disorders
• Tubulointerstitial diseases
• Complement-mediated kidney injury
• Cystic kidney disease
• Familial hypertension syndromes
• Transplant-related risk assessment

This course addresses one of the most important transitions occurring in nephrology today: the movement of nephrogenetics from research laboratories into routine clinical practice.

Course Details

• Event: ASN Kidney Week 2025 Early Program
• Program: Genetics in Clinical Nephrology
• Date: November 5, 2025
• Location: George R. Brown Convention Center, Houston, Texas
• Target Audience: Nephrologists, physician-scientists, transplant nephrologists, pediatric nephrologists, genetic counselors, and renal researchers

The Growing Role of Genetics in Everyday Nephrology

Historically, genetic kidney disease was often viewed as a niche subspecialty relevant primarily to rare syndromes or pediatric nephrology.

That perspective has changed dramatically.

Modern sequencing technologies now reveal that a substantial proportion of adults with:

• CKD of unclear cause
• FSGS
• atypical hemolytic uremic syndrome
• inherited cystic disease
• familial nephropathies
• early-onset hypertension
• unexplained proteinuria

may harbor clinically actionable genetic abnormalities.

The course repeatedly emphasizes that genetic testing is no longer reserved for academic curiosity alone. Instead, genetic information increasingly influences:

• Diagnosis
• Prognosis
• Treatment selection
• Transplant candidacy
• Family counseling
• Living donor evaluation
• Long-term surveillance strategies

Understanding Genetic Testing Modalities

One of the most clinically valuable sections of the program focuses on selecting the appropriate genetic testing strategy.

Topics include:

• Next-generation sequencing (NGS) panels
• Whole exome sequencing (WES)
• Whole genome sequencing (WGS)
• Indications for each modality
• Strengths and limitations of testing platforms

Many nephrologists encounter uncertainty regarding:

• Which patients should undergo testing
• Which test to order
• How broad sequencing should be
• When testing meaningfully changes management

The symposium appropriately focuses on practical decision-making rather than purely technical genomic theory.

Clinical interpretation becomes especially challenging when balancing:

• Diagnostic yield
• Cost considerations
• Incidental findings
• Ethical implications
• Clinical utility

Variant Interpretation & ACMG Classification

A major source of anxiety among clinicians involves interpreting complex genetic reports.

The course directly addresses this issue through workshop-based sessions reviewing:

• ACMG classification systems
• Pathogenic variants
• Likely pathogenic variants
• Variants of uncertain significance (VUS)
• Benign findings
• Clinical correlation strategies

One recurring challenge in nephrogenetics involves understanding that not every detected mutation necessarily explains the patient’s disease.

The program appropriately emphasizes cautious interpretation, particularly when encountering VUS findings that may create confusion for both clinicians and patients.

APOL1, Alport Syndrome & Transplant Risk Assessment

The transplant nephrology discussions are particularly important given the growing role of genetics in donor evaluation.

Topics include:

• APOL1-mediated kidney disease
• Alport syndrome
• Hereditary nephropathies
• Living donor screening
• Familial risk assessment

Modern transplant medicine increasingly requires careful genetic evaluation to avoid unintentionally exposing living donors to future renal risk.

Clinical decision-making becomes especially difficult when:

• Potential donors carry high-risk APOL1 variants
• Family members share hereditary nephropathies
• Genetic penetrance remains uncertain
• Long-term donor outcomes are unclear

The symposium explores how genetic findings can fundamentally alter transplant planning and donor selection strategies.

Precision Therapies in Genetic Kidney Disease

The course also reviews emerging therapies targeting specific molecular pathways involved in inherited kidney disorders.

Topics include:

• ADPKD therapeutics
• Complement-mediated TMA
• Pathway-specific treatment strategies
• Precision nephrology approaches
• Genotype-directed therapy

This reflects one of the most important conceptual shifts in nephrology:
moving from broad supportive management toward mechanism-targeted treatment.

In diseases such as complement-mediated thrombotic microangiopathy, understanding the underlying genetic defect increasingly determines:

• Therapeutic selection
• Complement inhibitor use
• Relapse risk
• Long-term prognosis

Thrombotic Microangiopathy & Complement Genetics

The TMA-focused sessions review:

• Complement pathway abnormalities
• Genetic susceptibility
• Atypical HUS mechanisms
• Diagnostic interpretation
• Precision treatment implications

Many clinicians continue finding TMA syndromes diagnostically challenging due to overlapping clinical presentations and evolving molecular classifications.

The course provides clinically grounded discussions that help bridge molecular understanding with bedside management.

Rare Kidney Disease Registries & Big Data Integration

The symposium also explores how large-scale genomic projects are reshaping nephrology classification systems.

Topics include:

• Rare Diseases Registry (RaDaR)
• 100,000 Genomes Project
• Big data nephrology
• Reclassification of kidney diseases
• Genotype-phenotype correlation

These discussions highlight how genomic medicine is increasingly redefining disease categories that were once based primarily on histopathology or clinical phenotype alone.

Family History & Ethical Complexity in Nephrology Genetics

The workshop sessions extend beyond laboratory interpretation and address the human side of nephrogenetics.

Topics include:

• Family history collection
• Genetic counseling principles
• Ethical issues in testing
• Living donation ethics
• Disclosure challenges
• Familial disease communication

In practice, genetic findings frequently affect entire families rather than isolated individuals.

Clinicians must therefore navigate difficult conversations regarding:

• Hereditary risk
• Predictive testing
• Reproductive implications
• Living donor eligibility
• Psychological impact of genetic diagnoses

The symposium appropriately recognizes that nephrogenetics requires both scientific literacy and communication skills.

Real-World Nephrogenetic Case Studies

The case-based sessions demonstrate how genetic diagnoses can directly alter patient management.

Examples include:

• Reclassification of CKD etiology
• Avoidance of unnecessary immunosuppression
• Earlier diagnosis of inherited disease
• Family screening strategies
• Precision treatment selection
• Transplant risk modification

These discussions help clinicians appreciate the real-world clinical relevance of genetic nephrology beyond theoretical molecular medicine.

Educational Approach

The course combines:

• Expert faculty lectures
• Interactive workshops
• Clinical case reviews
• Small-group discussions
• Ethical and practical decision-making sessions

This structure is particularly valuable because many clinicians remain uncomfortable integrating genomic medicine into daily practice despite rapidly increasing availability of testing.

What’s Included

• Advanced nephrogenetics education
• Genetic testing interpretation workshops
• Precision nephrology discussions
• Transplant genetics updates
• Complement-mediated disease reviews
• Real-world nephrogenetic case studies
• Ethical and counseling considerations

Target Audience

This course is ideal for:

• General nephrologists
• Transplant nephrologists
• Pediatric nephrologists
• Physician-scientists
• Genetic counselors
• Internal medicine physicians
• Nephrology fellows and trainees
• Researchers in renal genetics

Why This ASN Genetics Course Matters

Genomic medicine is rapidly transforming nephrology from a specialty focused primarily on physiology and histopathology into one increasingly guided by molecular diagnosis and precision therapeutics. As genetic testing becomes more accessible, clinicians are expected not only to order genomic studies, but also to interpret complex findings and integrate them into real-world patient care.

The ASN Kidney Week Genetics in Clinical Nephrology 2025 course addresses this growing need through a clinically practical and highly relevant review of nephrogenetics, hereditary kidney disease, transplant risk assessment, and genomic medicine integration. For nephrologists seeking confidence in navigating modern renal genetics, this program provides an important bridge between molecular science and daily clinical practice.